(Q35596959)

9 August 2017

1 reference

title

Prevention of Staphylococcus aureus infections among surgical patients: beyond traditional perioperative prophylaxis (English)

1 reference

9 August 2017

main subject

Staphylococcus aureus

1 reference

1

Trish M Perl

1 reference

9 August 2017

language of work or name

1 reference

1 November 2003

1 reference

9 August 2017

1 reference

9 August 2017

volume

134

1 reference

9 August 2017

issue

5 Suppl

1 reference

9 August 2017

page(s)

S10-7

1 reference

Nosocomial infections in surgical patients in the United States, January 1986-June 1992. National Nosocomial Infections Surveillance (NNIS) System

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

An overview of nosocomial infections, including the role of the microbiology laboratory

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

Starting to learn about the costs of nosocomial infections in the new millennium: where do we go from here?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

Hospital reimbursement patterns among patients with surgical wound infections following open heart surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

The Nature of Adverse Events in Hospitalized Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

The economic impact of Staphylococcus aureus infection in New York City hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

New approaches to reduce Staphylococcus aureus nosocomial infection rates: treating S. aureus nasal carriage

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

Nasal colonization with methicillin-resistant Staphylococcus aureus on admission to the surgical intensive care unit increases the risk of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

Head-injured patients who are nasal carriers of Staphylococcus aureus are at high risk for Staphylococcus aureus pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

Bacterial interference treatment of recurrent furunculosis. 2. Demonstration of the relationship of strain to pathogeneicity

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

CONTROL OF A STAPHYLOCOCCAL OUTBREAK IN A NURSERY, USE OF BACTERIAL INTERFERENCE

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

Multiple Infections among Newborns Resulting from Colonization withStaphylococcus aureus502A

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

Bacterial interference in the therapy of recurrent staphylococcal infections. Multiple abscesses due to the implantation of the 502A strain of staphylococcus

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

Randomized controlled trial of prophylactic rifampin for peritoneal dialysis-related infections

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

Randomized double-blinded trial of rifampin with either novobiocin or trimethoprim-sulfamethoxazole against methicillin-resistant Staphylococcus aureus colonization: prevention of antimicrobial resistance and effect of host factors on outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

Failure of oral ciprofloxacin in suppressing Staphylococcus aureus carriage in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

Staphylococcus aureus nasal carriage in hemodialysis patients. Its role in infection and approaches to prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

Effect of rifampin and bacitracin on nasal carriers of Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

Emergence of resistance during mupirocin treatment: is it a problem in clinical practice?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with calcium mupirocin ointment. The Mupirocin Collaborative Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

Nasal and cutaneous carriage of Staphylococcus aureus in hemodialysis patients: the effect of nasal mupirocin

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

The use of nasal mupirocin ointment to prevent Staphylococcus aureus bacteraemias in haemodialysis patients: an analysis of cost-effectiveness.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

The influence of calcium mupirocin nasal ointment on the incidence of Staphylococcus aureus infections in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

Elimination of nasal carriage of Staphylococcus aureus in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

Reduction of Staphylococcus aureus nasal carriage and infection in dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

Reduction of surgical-site infections in cardiothoracic surgery by elimination of nasal carriage of Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

Intranasal mupirocin reduces sternal wound infection after open heart surgery in diabetics and nondiabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

Prophylactic mupirocin could reduce orthopedic wound infections. 1,044 patients treated with mupirocin compared with 1,260 historical controls

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

CDC definitions for nosocomial infections, 1988

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

Clinical and economic effects of mupirocin calcium on preventing Staphylococcus aureus infection in hemodialysis patients: a decision analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

Cost-effectiveness of perioperative mupirocin nasal ointment in cardiothoracic surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

Emerging elevated mupirocin resistance rates among staphylococcal isolates in the SENTRY Antimicrobial Surveillance Program (2000): correlations of results from disk diffusion, Etest and reference dilution methods

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

Biochemical basis of mupirocin resistance in strains of Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

Mupirocin-resistant Staphylococcus aureus in a specialist school population

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

Transmissible mupirocin resistance in Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

Bacterial adherence to nasal mucosal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900391-X

7 January 2021

10.1016/S0039-6060(03)00391-X

Identifiers

DOI

1 reference

9 August 2017

1 reference